Münster / Berlin: Dr. Reuter TV is going to cover co.don AG (Berlin). co.don AG is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects.
In many cases the use of the company’s patented pharmaceutical product can avert or delay the need for joint and spinal disc replacement surgery. Orthopaedic, accident and neuro-surgeons are increasingly applying these regenerative therapy methods.
Matthias Meissner, CEO of co.don AG, describes the market for cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects. He reveals how defective articular cartilage can be repaired and talks about the status of European market approval. Finally, Meissner talks about how co.don AG managed to increase sales over 20% in Q4 2015 compared to Q4 2014.
The interview will be published shortly on www.dr-reuter.tv.